URAC names CVS Caremark drug management program awards finalist
WOONSOCKET, R.I. CVS Caremark’s Drug Therapy Management program has been selected by independent accrediting organization URAC as a finalist in its Best Practices in Health Care Consumer Empowerment and Protection Awards competition.
URAC will honor CVS Caremark and other finalists at the URAC 2009 Best Practices Conference & Exhibit on April 1 and 2 in Orlando, Fla.
“The Best Practices Awards and Conference provide a unique opportunity for leaders in health care management to learn what premier companies are doing to advance consumer protection and empowerment,” said Alan Spielman, URAC’s president and chief executive officer. “It is a one-of-a-kind conference, designed to inspire the industry as a whole to rapidly adopt proven practices that advance patient safety and empower consumers with improved decision-making tools.”
According to CVS Caremark, the goal of the CVS Caremark Drug Therapy Management program is to improve the outcome of drug therapy by providing patients with access to specially trained clinical pharmacists for one-on-one medication counseling. Patients who are taking multiple medications who have prescriptions from a number of different health care providers are invited to participate in an individualized counseling session with a clinical pharmacist to review their pharmacy health needs and identify any potential issues with compliance, efficacy, dosing and interactions. Once enrolled in the program, an electronic record is developed and kept up-to-date for the patient, along with an individualized care plan and regular follow-up appointments via the telephone with their assigned clinical pharmacist.
“The Drug Therapy Management program provides patients with personalized support from a clinical pharmacist who tracks their pharmacy health care needs and ensures coordinated communication and care between the patient and their health care providers,” said Elaine Manieri, vice president of clinical product management for CVS Caremark. “This program is another example of how CVS Caremark applies our Proactive Pharmacy Care approach in our interactions with patients to enable them to have the information they need to make educated choices about their pharmacy health care.”
Kirby Lester completes sale of pill-counting machines to supplier in Iraq
LAKE FOREST , Ill. Kirby Lester announced Thursday that it had sold several of its KL 15df pill-counting machines to Najmat Burgan, a medical and hospital goods supplier based in Kuwait City.
The company said the recent sale was part of its growing international presence. In the past three months, it has sold its devices to clients in Saudi Arabia, Botswana, Greece, Honduras and others, bringing its total number of customers to more than 30,000.
“When you consider all of the different medications, dispensing methods and manufacturing practices across the globe, only Kirby Lester can address the needs of all customers as well as deliver absolute counting accuracy,” Kirby Lester vice president for business development Christopher Thomsen said in a statement. “No other pharmacy technology has such broad appeal, bridges all of these differences and provides a universal solution.”
Waxman voted House chairman of the Committee on Energy and Commerce
WASHINGTON Rep. Henry Waxman, D-Calif., on Thursday was voted in as chairman of the Committee on Energy and Commerce for the House of Representatives, which oversees all legislation surrounding health and health services, including food and drug.
“I am honored by the vote of the Democratic Caucus,” Waxman stated. “We are at a unique moment and have an opportunity that comes only once in a generation. I will work with all parts of our Caucus and across the aisle to deliver the change that the American public expects us to deliver.”
“Some of the most important challenges we face—energy, climate change and health—are under the jurisdiction of the Commerce Committee,” Waxman wrote earlier this month in a statement explaining his pursuit of the Commerce Committee Chair. “In large measure, our success as Congress will depend on how the Commerce Committee performs. Enacting comprehensive energy, climate and health care reform will not be easy. But my record shows that I have the skill and ability to build consensus and deliver legislation that improves the lives of all Americans.”
Waxman helped engineer the generics industry as co-author of the Hatch-Waxman Act, which promotes generics while leaving in tact a financial incentive the research and development of branded pharmaceuticals. And while Waxman may be a fan of the generics industry, he has not in the past supported dietary supplements. Waxman has repeatedly called for greater regulation of dietary supplements and has proposed revisiting the Dietary Supplement Health and Education Act, which governs how supplements are regulated.
However, outgoing chairman Rep. John Dingell, D-Mich., was also critical of the dietary supplement industry, having in the past partnered with Waxman on several pieces of legislation regarding regulation of dietary supplements.